MedTrace Logo

Multi-omics Analysis of Women With PCOS and Obesity Compared With Non-PCOS Obese Controls

NCT05468476 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2023-05-01

No results posted yet for this study

Summary

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in reproductive-aged women， which associated with increased risks to develop metabolic disorders, including cardiovascular diseases, diabetes mellitus, and cerebrovascular diseases. The precise pathogenesis of PCOS remains unknown but is thought to be multifactorial, comprising genetic and environmental factors .

Conditions

  • Polycystic Ovary Syndrome

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Zhang Manna

    lead OTHER

Principal Investigators

  • Manna Zhang, Ph.D · Department of Endocrinology, Shanghai Tenth People's Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2022-08-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05468476 on ClinicalTrials.gov